ARGX - argenx SE Projected Sales Volume

Official company branding of argenx (ARGX)

Partners' production capacities are operating at full throttle, ensuring the output of immunological agents without downtime. The stability of argenx SE (ARGX) is guaranteed by its flagship Vyvgart, which generates high free cash flow. The company's sales guidance confirms this resilience, where the value 7.16 represents the current figure. Growth prospects are based on the expansion into new nosologies and successful late-stage pipeline trials.

ARGX - argenx SE Projected Sales Volume over the range 07/04/2022 - 11/16/2026

ARGX (Argenx): analytical breakdowns and indicator data

- stock value and consensus price forecast:
Analysis of all company metrics:ARGX Argenx
Brand item of argenx N.V.

This indicator measures projected revenue, separating sustainable market trends from short-term anomalies and manipulative adjustments to calculation models. By analyzing the expected sales volume of argenx SE, an investor can assess the monetization potential of the company's extensive portfolio of immunological drugs, where the multi-indication application of the flagship product and a robust research pipeline minimize patent risks and ensure long-term diversification of cash flows.

Who argenx SE competes with

Company Projected Revenue BioNTech Group (BNTX)|Abivax S.A. - Company Revenue Forecast|Projected Sales Volume ADMA (admabiologics.com)|Protagonist Corp (PTGX) - Company Expected Sales Volume|immunovant.com - Projected Sales Volume|KNSA - Projected Sales Volume|Grifols (GRFS) - Company Projected Revenue|Company Revenue Forecast ADPT|Company Projected Revenue Celldex|AUPH: Company Future Revenue|Projected Sales Volume BCRX|Projected Sales Volume Vera Therapeutics (VERA)|Dianthus Therapeutics - Company Future Sales Volume|Pharvaris - Company Projected Revenue|ABCL - Company Projected Revenue|TRML - Projected Sales Volume|PGEN: Projected Sales Volume|Company Revenue Forecast PHAR|Company Future Sales Volume NKTR|UPB: Company Future Revenue|Company Projected Revenue zenasbio.com (ZBIO)|IMNM (Immunome Corp) - Company Future Revenue|Projected Sales Volume GOSS (Gossamer Bio, Inc.)|KALV (KalVista Pharmaceuticals) - Company Expected Revenue|SEPN - Company Projected Revenue|Company Future Revenue PVLA (Pieris Pharma)|Savara Pharma (SVRA) - Company Projected Revenue|Rigel Pharmaceuticals Inc (RIGL) - Projected Sales Volume|Company Projected Revenue AnaptysBio|Astria Therapeutics - Company Expected Revenue|Projected Sales Volume ENGN|Company Projected Revenue Volume RAPT|Company Projected Revenue Aerovate Therapeutics, Inc. JBIO|Aclaris Therapeutics (ACRS) - Company Expected Sales Volume|KYTX: Company Future Sales Volume|Company Future Sales Tiziana Life Sciences TLSA|CABA: Projected Sales Volume|Company Expected Sales Volume Ventyx Biosciences Inc. (VTYX)|Company Future Sales Volume THTX|Avalo Therapeutics, Inc (AVTX) - Company Future Sales|Projected Sales Volume ELDN|Company Future Sales Volume agenusbio.com AGEN|Projected Sales Volume CLYM (climbbio.com)|Projected Sales Volume Zura Bio Ltd ZURA|ATYR - Company Projected Revenue|Adagene Inc (ADAG) - Company Future Sales Volume|IMA: Projected Sales Volume|Shattuck Therapeutics (STTK) - Projected Sales Volume|Company Projected Revenue equilliumbio.com|CNTB: Company Future Revenue|Projected Sales Volume IMUX|ATRA (Atara Bio) - Company Future Revenue|Company Projected Revenue InflaRx N.V. IFRX|x4pharma.com - Company Projected Revenue|ACET - Company Projected Revenue|Company Future Revenue CELU (celularity.com)|INMB: Projected Sales Volume|Barinthus Biotherapeutics Corp - Company Future Revenue|Company Future Sales Volume KZR|Company Future Sales Volume SAB Biotherapeutics (SABS)|Company Future Sales Volume AKTX (Akari Therapeutics Plc)|Company Future Sales Volume Enlivex Therapeutics Ltd. ENLV|Q32 Bio Corp - Company Future Sales Volume|GOVX - Company Future Sales Volume|EDSA - Company Projected Revenue|Company Future Revenue IBIO (iBio, Inc.)|CARM: Projected Sales Volume|XTL Biopharmaceuticals, Ltd. (XTLB) - Projected Sales Volume|Company Projected Revenue boltbio.com|Projected Sales Volume hcwbiologics.com|Company Future Sales Volume APVO (aptevotherapeutics.com)|Company Future Sales AIM ImmunoTech, Inc.|Projected Sales Volume ADTX (Aditxt)|Company Future Revenue GRI|XRTX - Company Projected Revenue|HIND: Company Projected Revenue|REVB (Revelation Biosciences Corp) - Company Future Sales Volume|Company Revenue Forecast INDP|Company Projected Revenue Scinai Immunotherapeutics Ltd|calcimedica.com (CALI) - Company Future Sales|Company Projected Revenue Affimed NV (AFMD)|Allakos - Company Revenue Forecast|Company Projected Revenue HOOKIPA Pharma, Inc. HOOK|IGMS - Company Future Sales Volume|ITOS: Company Future Sales Volume|Company Expected Sales Volume Ocean Biomedical|TCBP: Projected Sales Volume|Third Harmonic Bio, Inc - Company Future Revenue